Finlee

dabrafenib mesilate · Novartis Europharm Limited

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Finlee, covering 2026-03-30 to 2026-03-30. Get the full timeline:

Most recent: EMA Authorised: Finlee (dabrafenib mesilate) — Novartis Europharm Limited